Posts Categorized:

Featured Interview – Martin Kohn

Dr. Martin Kohn is the Chief Medical Scientist for Health Care Delivery at IBM Research. Here he discusses work underway to apply the IBM Watson supercomputer to meet needs in the healthcare field today.

How Far along is the IBM “Watson” project in medical applications?

Ultimately Watson makes its real contribution in unstructured data analysis. So that’s reasonably far along. Not complete, but reasonably far along, and we’re getting progressively more complicated in the kinds of information being presented to Watson.

For instance, when Watson played “Jeopardy” it had to be taught the context of “Jeopardy.” “Jeopardy” is answers, then you have to come back with the question. So we’re doing the same thing in health care. We’re feeding it information and questions, and teaching it the reasoning it needs for health care.

As far as an actual implementation, we have spent a lot of time in the last year or so going around the country talking to health care organizations to work with them and have them help us identify what kinds of decisions — what challenges in health care organization management — would be valuable for Watson.

One of our early implementations is with WellPoint, the very large healthcare payer organization. One of the implementations that is being developed with them is the process of prior approval for interventions. It’s a very bureaucratic, complicated process that’s time-consuming for all participants. For instance, WellPoint has a panel of nurses that review these requests, and they can either approve them or decide it needs to be sent to a physician panel; so there’s a lot of time involved, a lot of effort on the part of the providers and the payers. There was an article in “Health Affairs” a couple of months ago that estimated for the average physician in the United States, the cost of interacting with payers was $85,000 per year, roughly 14 or 15% of their total practice revenue. So, if Watson is able to help make these decisions — yes this is a request that should be approved, or should go to the physician panel — and make this more efficient, faster. And with Watson being interactive, for example, instead of the physician having to wait a couple of weeks, to get the response that more information is needed; interacting with Watson can be real-time and that may make the whole process more reliable, less expensive, and more efficient.

About the eNewsletter

The IEEE Life Sciences eNewsletter is a new initiative to bring forth interesting articles and informative interviews within the exciting field of life sciences every month. Please subscribe to the eNewsletter to receive notification each month when new articles are published.

May 2012 Contributors

Dr. Martin KohnDr. Martin Kohn is Chief Medical Scientist for Care Delivery Systems in IBM Research. He is a leader in IBM's support for the transformation of healthcare, including development of personalized care, outcomes-based models and payment reform. Read more

Chalapathy NetiChalapathy Neti is currently the Director and Global Leader, Healthcare Transformation, at IBM Research. In this role he leads IBM's global research, spanning 9 worldwide labs, on information technology innovation for healthcare transformation. Read more

Dr. Shahram EbadollahiDr. Shahram Ebadollahi is the senior manager of the Healthcare Systems and Analytics Research at IBM T.J. Watson Research Center in New York. He and the team of scientists working with him conduct research in the broad area of health informatics. Read more

David A. FerrucciDavid A. Ferrucci is an IBM Fellow and the Principal Investigator for the DeepQA Watson/ Jeopardy! project. He has been at the T. J. Watson Research Center since 1995, where he leads the Semantic Analysis and Integration Department. Read more

Nitish V. ThakorNitish V. Thakor is a Professor of Biomedical Engineering at Johns Hopkins University, Baltimore, USA, as well as the Director of the newly formed institute for neurotechnology, SiNAPSE, at the National University of Singapore. Read more

Dr. Christopher VoigtDr. Christopher Voigt is an Associate Professor in the Department of Biological Engineering at MIT, and is co-director of the Center for Integrative Synthetic Biology. Previously, he was a member of the faculty in the Department of Pharmaceutical Chemistry at University of California, San Francisco. Read more